0 avis
FXYD2 antisense oligonucleotide provides an efficient approach for long-lasting relief of chronic peripheral pain
Archive ouverte
Edité par CCSD ; American Society for Clinical Investigation -
International audience.
AP, and SV have filed patents based on this work ("Methods and compositions for treating neuropathic pain," no. WO2016005422; and "Antisense oligonucleotides and their use for the treatment of pain," no. WO2021069654).